Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036282 · ClinicalTrials.gov registry record · Phase 4
Cognitive Skills Training Using Computer for Patients With Severe Mental Illness
A Phase 4 study of Schizophrenia and Schizoaffective Disorder, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 448
- Enrollment target
- 1
- Study location
NCT01036282: Completed Phase 4 study of Schizophrenia and Schizoaffective Disorder, sponsored by Nathan Kline Institute for Psychiatric Research.
NCT01036282 is a Phase 4 study of Schizophrenia and Schizoaffective Disorder that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 448 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (106% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01036282, a Phase 4 study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 448 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.
Primary Outcome
Comprehensive battery of neuro-cognitive tests
Conditions Studied
Interventions
- BEHAVIORAL Computerized Cognitive Skill Training
- BEHAVIORAL CRT and Social Cognition
Study Locations (1)
New York
- Manhattan Psychiatric Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2003-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
What the finished NCT01036282 record still lists
NCT01036282 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (106% higher).
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Computerized Cognitive Skill Training is the first listed.
NCT01036282 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01036282 about?
NCT01036282 is a clinical study titled "Cognitive Skills Training Using Computer for Patients With Severe Mental Illness". The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.
What is the current status of trial NCT01036282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 448 participants. The study started on 2003-02. Estimated completion is 2016-12.
What conditions does trial NCT01036282 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT01036282?
The interventions under investigation include: Computerized Cognitive Skill Training (BEHAVIORAL), CRT and Social Cognition (BEHAVIORAL).
Who is sponsoring clinical trial NCT01036282?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01036282 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01036282's enrollment target sits among peer trials
448 42nd of 315 higher than 274 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
CLOZAPINE Response in Biotype-1
RECRUITING · Phase 4
-
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
RECRUITING · Phase 4
-
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
RECRUITING · Phase 4
-
Anti-Inflammatory Challenge in Schizophrenia
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia